MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/cbdd.14337

Медицинская библиотека · Chemical biology & drug design · 2023

Berberine derivatives as inhibitors of acetylcholinesterase: A systematic review.

Singh Yash Pal, Kumar Harish

Систематический обзорСтатьяПеревод пока не подготовлен

Аннотация

Alzheimer's disease (AD) is a chronic age-related neurodegenerative brain disorder characterized by the impairment of memory accompanied by worsening of thinking ability of an individual. The exact pathophysiology of AD is not fully understood. However low level of the neurotransmitter named acetylcholine (ACh), aggregation of Aβ peptide into toxic Aβ plaque, hyperphosphorylation of tau, bio-metal imbalance, and oxidative stress are the main hallmarks of this disease. Due to the complex pathophysiology of AD, no specific treatment is available in the market, and treatment is only limited to the symptomatic relief. So, there is an urgent need for the development of new drug candidate, which can have disease-modifying effect and improve learning and memory in AD patient. Therefore, berberine-based multifunction compounds with potential cholinesterase inhibitory properties were reviewed in this article. Structure-activity relationship (SAR) and biological activity provide highlights on the new derivatives used for the management of AD.

Для цитирования: Singh Yash Pal, Kumar Harish. Berberine derivatives as inhibitors of acetylcholinesterase: A systematic review.. Chemical biology & drug design. 2023. DOI: 10.1111/cbdd.14337.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.